Why are we at $.90? It's as simple as more selling than buying pressure over the past few months. Mediquip directors selling 4 million shares, Private placement holders from $.10 selling their shares, restricted shares being freed up due to the regulation change shortening the holding period from 1yr to 6 months selling shrares. We were trading at $2.35 before all of the selling took place. That was also before Mako, before Dahlman Rose revising their estimates up, and way before Flotech. Not to mention the credit/mortgage crisis and its effect on the entire market. When were trading at over $2.00 before we were overvalued by quite a bit. Now it is the exact opposite. I promise you there will be a time again when we are overvalued. But that is dollars north of here. Flotech is a game changer. Whenever we uplist to the AMEX it will not be an IPO. Our IPO was our reverse merger. Someday we may have a secondary offering and in that case the underwriters would value us much more fairly.